Topalliance Biosciences Europe Limited: medicines

Loading your page…

Sources and licences

Medicine	Substance	Country	Status	Authorised
LOQTORZIConcentrato per soluzione per infusione	Toripalimab	Italy	Authorised
Loqtorzi	Toripalimab	EU (EMA)	Authorised	2024
LOQTORZI 240 mg concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie	Toripalimab	Netherlands	Authorised	2024
LOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSION240 mg · Concentrado para solución para perfusión	Toripalimab	Spain	Marketed	2025

Country	Medicines	Current	Past	Companies
Spain	1	1	0	Companies

Medicine	Substance	Country	Status	Authorised
LOQTORZIConcentrato per soluzione per infusione	Toripalimab	Italy	Authorised
Loqtorzi	Toripalimab	EU (EMA)	Authorised	2024
LOQTORZI 240 mg concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie	Toripalimab	Netherlands	Authorised	2024
LOQTORZI 240 MG CONCENTRADO PARA SOLUCION PARA PERFUSION240 mg · Concentrado para solución para perfusión	Toripalimab	Spain	Marketed	2025

Country	Medicines	Current	Past	Companies
Spain	1	1	0	Companies

European Union (EMA)	1	1	0	Companies All medicines

Italy	1	1	0	Companies All medicines

Netherlands	1	1	0	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

All 9 sources

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

Topalliance Biosciences Europe Limited

Medicines

Countries

Know your medicines, with the sources.

Topalliance Biosciences Europe Limited

Medicines

Countries

Know your medicines, with the sources.

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Ireland: more companies